Sweden Genomics Market Size & Outlook, 2024-2033
Related Markets
Sweden genomics market highlights
- The Sweden genomics market generated a revenue of USD 179.0 million in 2024 and is expected to reach USD 449.5 million by 2033.
- The Sweden market is expected to grow at a CAGR of 10.8% from 2025 to 2033.
- In terms of segment, functional genomics was the largest revenue generating application in 2024.
- Functional Genomics is the most lucrative application segment registering the fastest growth during the forecast period.
Genomics market data book summary
| Market revenue in 2024 | USD 179.0 million |
| Market revenue in 2033 | USD 449.5 million |
| Growth rate | 10.8% (CAGR from 2025 to 2033) |
| Largest segment | Functional genomics |
| Fastest growing segment | Functional Genomics |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
| Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, Sweden accounted for 0.8% of the global genomics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Spain genomics market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 2,843.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genomics Market Scope
Genomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Oxford Nanopore Technologies PLC | View profile | 1133 | Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQ | https://www.nanoporetech.com |
| Eppendorf | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | https://dasgip.de |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | https://www.23andme.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | https://www.pacb.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| GE Aerospace | View profile | 125000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | https://www.geaerospace.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Sweden genomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 31.45% in 2024. Horizon Databook has segmented the Sweden genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2021 to 2033.
In Sweden, increased usage of genomics in clinical practice for proper diagnosis and treatment is driving the market. Moreover, Genomic Medicine Sweden (GMS) was started in 2017. This initiative aims to contribute to personalized medicine and enhance healthcare in the country. The main focus of the GMS initiative will be individuals with cancer, rare disorders, and infectious disorders.
In addition, the collaboration between SciLifeLab Clinical Genomics platform and GMS to develop precision diagnostics has enabled the use of WGS for rare diseases in hospitals. Similarly, in April 2022, Danish National Genome Center and Genomic Medicine Sweden entered into a partnership to develop advanced precision medicine.
This initiative aims to develop and implement novel solutions and models to deliver genomic-based precision medicine at the national level. Thus, increasing adoption of genome sequencing applications in hospitals and laboratories has further boosted market growth.
Reasons to subscribe to Sweden genomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sweden genomics market databook
-
Our clientele includes a mix of genomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden genomics market , including forecasts for subscribers. This country databook contains high-level insights into Sweden genomics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Sweden Biomarker Discovery - Genomics Market, 2024 - 2033 (US$M)
Sweden Genomics Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
